Tech & Innovation

US and China Cooperate to Limit AI-Enabled Biological Risks
Tech & Innovation US and China Cooperate to Limit AI-Enabled Biological Risks

Bypassing traditional bureaucratic bodies like the World Health Organization may allow for more agile and direct coordination between the U.S. and China on biosecurity. As we navigate the complex landscape of 2026, the intersection of advanced large language models and synthetic biology has

Scorpion Venom Peptides Emerge as New Liver Disease Treatments
Tech & Innovation Scorpion Venom Peptides Emerge as New Liver Disease Treatments

The rhythmic twitch of a scorpion’s tail has long signaled a lethal threat to the unwary, but today that same biological weaponry is being repurposed into a sophisticated pharmaceutical instrument for mending the human liver. While these arachnids have survived for hundreds of millions of years by

Can Synthetic Biology Replace Chemical Pesticides?
Tech & Innovation Can Synthetic Biology Replace Chemical Pesticides?

Existing natural microbial solutions have historically struggled to bridge the performance gap between environmental stewardship and the high yields required for commercial viability. This tension has forced the global agricultural industry into a state of chemical dependency, where approximately

Can AI-Designed Viruses Solve Antibiotic Resistance?
Tech & Innovation Can AI-Designed Viruses Solve Antibiotic Resistance?

Data filtering initiatives, such as excluding eukaryotic viruses from training sets, represent the first steps in preventing AI models from learning how to design human pathogens. This protective measure is increasingly vital as the intersection of artificial intelligence and the life sciences

AI-Driven Geroprotection Therapeutics – Review
Tech & Innovation AI-Driven Geroprotection Therapeutics – Review

The technological ability to decode the complex molecular signatures of human aging and intervene with precision-engineered molecules has shifted from theoretical biology toward a measurable clinical reality. This evolution is driven by the sophisticated integration of generative artificial

TriMaster Trial Advances Precision Care in Type 2 Diabetes
Tech & Innovation TriMaster Trial Advances Precision Care in Type 2 Diabetes

While complex genetic clusters were once thought to be the key to precision medicine, new analysis suggests that routine clinical data may be just as effective for drug selection. For decades, the management of Type 2 diabetes has relied on a rigid, standardized protocol where patients are moved

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later